Arrangementer

På denne siden finner du nyheter og arrangementer som Medac deltar på.

  1. EAU19 (European Association of Urology)

    15 mars, 2019 - 19 mars, 2019

  2. Nordic Congress of Dermatology & Venereology 2019

    8 maj, 2019 - 11 maj, 2019

  3. NUF Congress 2019 (Nordisk Urologisk Forening)

    5 juni, 2019 - 8 juni, 2019

  4. EULAR 2019 (European league against rheumatism)

    12 juni, 2019 - 15 juni, 2019

Nyheter

Medac has received the Yellow Hand Award

Medac received the Yellow Hand Award for the second consecutive time during the European Conference Oncology Pharmacy. The Yellow Hand Award is given by ESOP, European Society of Oncology Pharmacy. The Yellow Hand Award is awarded to companies who ensure safe transportation and handling of cystostatics throughout the complete supply chain and was first given in […]

Press release – Medac at the EADV Congress

Real-life data demonstrate the potential of methotrexate in severe and moderately severe psoriasis First French guidelines for psoriasis therapy – subcutaneous MTX is First-Line Paris / Wedel (14 September 2018). Methotrexate (MTX) is established and proven as an effective systemic first-line therapeutic agent in the treatment of psoriasis.1  MTX is and remains the world’s most […]

Press release – First marketing authorisation worldwide for methotrexate in moderate psoriasis

Medac’s marketing authorisation extension gives many patients with psoriasis access to guidelines-based MTX therapy for the first time. Click here to view full Press release

Press release – Alacare®

Innovative therapeutic for the treatment of mild actinic keratoses – first self-adhesive patch for PDT The skin lesion actinic keratosis is associated with an estimated prevalence of up to 60 % in certain populations and bears a high disease burden being considered as precancerous The treatment option with the ALA-PDT patch has not only been […]

Press release

medac passes eco-audit and receives award for environmental management medac Gesellschaft für klinische Spezialpräparate mbH is innovative, successful, sustainable and environment-friendly. The pharmaceutical company has proven that economic prosperity and environmental responsibility are not necessarily a contradiction. To achieve perfect conditions for this objective, medac subjected itself to an auditing procedure according to EMAS and […]

Medac er ikke ansvarlig for innhold på andre websteder!